DeepMed Research

Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Comparing Meniscal Repair Biologic Augmentation: Marrow Venting Procedure Versus PRP (MVP Trial)

Not Applicable

Recruiting

Conditions: Meniscal Tear

Interventions: Other: Platelet Rich Plasma (PRP)
Other: Bone marrow venting procedure (BMVP)

First Posted Date: 2021-03-01

Last Posted Date: 2024-10-03

Lead Sponsor: University of Chicago

Target Recruit Count: 146

Registration Number: NCT04775004

Locations: 🇺🇸
University of Chicago Medicine, Chicago, Illinois, United States
🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
🇺🇸
University of Florida, Gainesville, Florida, United States

A Promotion and Implementation Project of HIV Pre-Exposure Prophylaxis Among High Risk Population

Not Applicable

Completed

Conditions: HIV Preexposure Prophylaxis

Interventions: Other: WeChat mobile mini-application

First Posted Date: 2021-02-15

Last Posted Date: 2024-10-03

Lead Sponsor: University of Chicago

Target Recruit Count: 1200

Registration Number: NCT04754139

Locations: 🇨🇳
Zhongnan Hospital of Wuhan University, Wuhan, China
🇨🇳
Guangzhou Eighth People's Hospital, Guangzhou, China

Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)

Phase 2

Recruiting

Conditions: Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia
ph+ Acute Lymphoblastic Leukemia

Interventions: Drug: Inotuzumab ozogamicin
Drug: Dasatinib
Drug: Dexamethasone
Drug: Methotrexate for Injection
Drug: Methotrexate
Drug: Vincristine
Drug: Ponatinib
Procedure: Allogenic Stem Cell Transplantation

First Posted Date: 2021-02-10

Last Posted Date: 2025-03-07

Lead Sponsor: University of Chicago

Target Recruit Count: 25

Registration Number: NCT04747912

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Community Network-driven COVID-19 Testing and Vaccination of Vulnerable Populations in the Central US

Not Applicable

Completed

Conditions: Covid19

Interventions: Other: Social Network Strategy + COVID-19 messaging

First Posted Date: 2021-02-08

Last Posted Date: 2024-10-10

Lead Sponsor: University of Chicago

Target Recruit Count: 1328

Registration Number: NCT04743908

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

A Dose-Finding and Efficacy Study of Venetoclax, CC-486, and Obinutuzumab in Follicular Lymphoma

Phase 1

Terminated

Conditions: Follicular Lymphoma

Interventions: Drug: Venetoclax
Drug: Obinutuzumab
Drug: CC-486

First Posted Date: 2021-01-25

Last Posted Date: 2024-05-16

Lead Sponsor: University of Chicago

Target Recruit Count: 2

Registration Number: NCT04722601

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Florbetaben PET Imaging in PPA

Completed

Conditions: Alzheimer Disease
Primary Progressive Aphasia

Interventions: Drug: Florbetaben F18
Device: PET

First Posted Date: 2021-01-22

Last Posted Date: 2024-10-16

Lead Sponsor: University of Chicago

Target Recruit Count: 1

Registration Number: NCT04720001

Locations: 🇺🇸
University of Chicago - American School Building, Chicago, Illinois, United States

Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments

Not Applicable

Recruiting

Conditions: Prostate Cancer

Interventions: Behavioral: Patient Education

First Posted Date: 2021-01-12

Last Posted Date: 2024-07-31

Lead Sponsor: University of Chicago

Target Recruit Count: 100

Registration Number: NCT04705038

Locations: 🇺🇸
University of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States

Diabetic Neuropathy in Spinal Cord Stimulator Patients

Recruiting

Conditions: Diabetes Mellitus
Neuropathic Pain
Vascular Diseases
Microvascular Changes
Pain, Chronic
Neuropathy
Vascular Stiffness

First Posted Date: 2020-12-29

Last Posted Date: 2025-03-10

Lead Sponsor: University of Chicago

Target Recruit Count: 25

Registration Number: NCT04687215

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer

Phase 1

Recruiting

Conditions: Endometrial Cancer

Interventions: Radiation: Hypofractionated Radiation
Other: Clinical Follow-Up and Assessments

First Posted Date: 2020-12-24

Last Posted Date: 2024-10-14

Lead Sponsor: University of Chicago

Target Recruit Count: 100

Registration Number: NCT04683653

Locations: 🇺🇸
University of Illinois at Chicago (UIC), Chicago, Illinois, United States
🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

and more 1 locations

Telotristat Ethyl for Reducing Intraoperative Carcinoid Crisis in Patients With Neuroendocrine Tumors

Phase 2

Withdrawn

Conditions: Neuroendocrine Tumors

Interventions: Drug: Telotristat Ethyl Oral Tablet

First Posted Date: 2020-12-17

Last Posted Date: 2021-12-17

Lead Sponsor: University of Chicago

Registration Number: NCT04672876

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy